290 related articles for article (PubMed ID: 28673748)
21. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
22. Malignant melanoma of the conjunctiva with intraocular extension.
Wenkel H; Rummelt V; Naumann GO
Arch Ophthalmol; 2000 Apr; 118(4):557-60. PubMed ID: 10766144
[TBL] [Abstract][Full Text] [Related]
23. BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.
Larsen AC; Dahl C; Dahmcke CM; Lade-Keller J; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
Acta Ophthalmol; 2016 Aug; 94(5):463-70. PubMed ID: 27009410
[TBL] [Abstract][Full Text] [Related]
24. Conjunctival melanomas harbor BRAF and NRAS mutations--response.
Griewank KG; Westekemper H; Schilling B; Livingstone E; Schimming T; Sucker A; Hillen U; Steuhl KP; Zimmer L; Schadendorf D
Clin Cancer Res; 2013 Nov; 19(22):6331-2. PubMed ID: 24170549
[No Abstract] [Full Text] [Related]
25. Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion.
Walsh-Conway N; Conway RM
Clin Exp Ophthalmol; 2009 Aug; 37(6):577-83. PubMed ID: 19702707
[TBL] [Abstract][Full Text] [Related]
26. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients.
Lally SE; Milman T; Orloff M; Dalvin LA; Eberhart CG; Heaphy CM; Rodriguez FJ; Lin CC; Dockery PW; Shields JA; Shields CL
Ophthalmology; 2022 Jun; 129(6):679-693. PubMed ID: 35085662
[TBL] [Abstract][Full Text] [Related]
27. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
Colby KA; Nagel DS
Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
29. [Intraocular invasion of melanoma of the conjunctiva].
Lommatzsch PK; Werschnik C; Gütz U
Klin Monbl Augenheilkd; 1999 Dec; 215(6):370-2. PubMed ID: 10637803
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting recurrence and metastasis in conjunctival melanoma.
Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
[TBL] [Abstract][Full Text] [Related]
31. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
32. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
Ekedahl H; Cirenajwis H; Harbst K; Carneiro A; Nielsen K; Olsson H; Lundgren L; Ingvar C; Jönsson G
Br J Dermatol; 2013 Nov; 169(5):1049-55. PubMed ID: 23855428
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival papilloma: features and outcomes based on age at initial examination.
Kaliki S; Arepalli S; Shields CL; Klein K; Sun H; Hysenj E; Lally SE; Shields JA
JAMA Ophthalmol; 2013 May; 131(5):585-93. PubMed ID: 23538642
[TBL] [Abstract][Full Text] [Related]
35. Multifocal melanoma of the conjunctiva in an African American patient with neurofibromatosis type 1.
Medina Mendez CA; Singh AD
Cornea; 2014 Jul; 33(7):750-1. PubMed ID: 24699564
[TBL] [Abstract][Full Text] [Related]
36. Anterior segment tumor biopsy using an aspiration cutter technique: clinical experience.
Petousis V; Finger PT; Milman T
Am J Ophthalmol; 2011 Nov; 152(5):771-5.e1. PubMed ID: 21794840
[TBL] [Abstract][Full Text] [Related]
37. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.
Khan S; Finger PT; Yu GP; Razzaq L; Jager MJ; de Keizer RJ; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Arch Ophthalmol; 2012 Jan; 130(1):57-64. PubMed ID: 21911649
[TBL] [Abstract][Full Text] [Related]
38. Two cases of BRAF-mutated, bulbar conjunctival melanoma, and review of the published literature.
Kiyohara T; Tanimura H; Miyamoto M; Shijimaya T; Nagano N; Nakamaru S; Makimura K; Iwai H
Clin Exp Dermatol; 2020 Mar; 45(2):207-211. PubMed ID: 31361915
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation.
Ulivieri A; Cardillo G; Manente L; Paone G; Mancuso AP; Vigna L; Di Stasio E; Gasbarra R; Girlando S; Leone A
Oncotarget; 2015 Aug; 6(23):19868-79. PubMed ID: 26305188
[TBL] [Abstract][Full Text] [Related]
40. Conjunctival melanomas harbor BRAF and NRAS mutations--Letter.
Weber JL; Smalley KS; Sondak VK; Gibney GT
Clin Cancer Res; 2013 Nov; 19(22):6329-30. PubMed ID: 24166902
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]